ACLS Meds Flashcards
MOA of adenosine
produces negative chronotropic effect on the SA and AV node
indication for adenosine
- stable PSVT
- questioning wide complex tachycardia as reentry SVT
precautions with adenosine
- poison/drug induced 2nd/3rd HB
- less effective if the pt is on theophylline or caffeine
- reduce if on dipyrdamole or carbamazepine
dose of adenosine
- 6 mg, 12 mg, 12 mg
- rapid push 1-3 sec with immediate flush 20 mL NS then elevation of the extremity
MOA of amiodarone
-affects Na, K and Ca channels
prolongs phase III of action potential
-also has alpha/beta blocking properties
indication from amiodarone
ventricular arrhythmias
precautions with amiodarone
- > 2.2g/24 associated with hypotension
- watch other QT prolonging drugs
- 1/2 life up to 40 days
- resembles T4 hormone
dose of amiodarone
- unstable: 1st dose 300 mg 2nd dose 150 mg in 3-5 min
- stable: 150 mg with maintenance 540 mg IV over 18 hrs at rate of 0.5 mg/min
MOA of aspirin
- inhibits platelet cyclooxygenase
- blocks thromboxane A2
indication for aspirin
ACS
precautions with aspirin
- relative contraindication: active ulcer/asthma
- absolute: hypersensitivity rxn
dose of aspirin
- 160-325 mg PO non-enteric coated/chewed
- 300 mg PR with cannot tolerate PO
MOA of atropine sulfate
- parasympatholytic: blocks parasympathetic tone (only sympathetic gets through)
- anticholinergic
indication for atropine sulfate
- bradycardia
- organophosphatae poisoning
precautions with atropine sulfate
worsen bradycardia Mobits II or 3rd degree
dose of atropine sulfate
- 0.5 mg IV Q3-5 min
- NOT exceeding 3 mg or 0.03 mg/kg